Community Pharmacy Assisting in Total Cardiovascular Health (CPATCH)
|ClinicalTrials.gov Identifier: NCT01509014|
Recruitment Status : Unknown
Verified January 2012 by University of Saskatchewan.
Recruitment status was: Active, not recruiting
First Posted : January 12, 2012
Last Update Posted : January 12, 2012
Despite proven benefits in reducing morbidity and mortality, many patients become nonadherent to statin therapy within the first year of starting. Due to their accessibility and frequent patient contact, pharmacists are well-positioned to improve medication adherence.
The purpose of this study is to determine whether a simple intervention by community pharmacists can improve statin adherence in new statin users.
|Condition or disease||Intervention/treatment|
|Statin Therapy Adherence||Behavioral: CPATCH intervention to support statin adherence|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||2250 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Study Start Date :||March 2010|
|Primary Completion Date :||November 2011|
|Estimated Study Completion Date :||January 2012|
Experimental: Pharmacy Intervention Arm
All patients receiving statins from pharmacies allocated to the pharmacist intervention arm of the study
Behavioral: CPATCH intervention to support statin adherence
Routine identification of new statin users (first year of therapy), consistent assessment of barriers to adherence at every dispensation for these patients, reassurance about efficacy and safety, and proactive response to identified adherence barriers.
No Intervention: Usual Care
Pharmacies not allocated to the intervention arm will serve as the control. They received no training on the CPATCH intervention and provide usual care to patients at their pharmacy.
- Mean statin adherence among all eligible new users of statin medications with at least 6 months of follow-up from index prescription [ Time Frame: 6 months ]All statin dispensations are captured by the prescription drug plan database. Mean adherence will be measured using the proportion of days covered (sum of days supply for statin prescriptions during study period divided by the number of days of observation). PDC will be adjusted for any days subject was hospitalized during study period.,
- Proportion of new statin users with adherence greater than or equal to 80% [ Time Frame: 6 months ]
- Persistence with statin use among patients with a minimum of 12 months of follow-up [ Time Frame: 6 months ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01509014
|College of Pharmacy and Nutrition, University of Saskatchewan|
|Saskatoon, Saskatchewan, Canada, S7n 5C9|